Mikkelsen K V, Andersen-Ranberg K, Hegedüs L
Odense Universitetshospital, geriatrisk afdeling G.
Ugeskr Laeger. 2001 May 14;163(20):2770-3.
In the elderly, thyroid dysfunction usually develops insidiously and is dominated by non-specific symptoms and clinical findings, typically related to normal aging or to age-associated disease. Case finding, in combination with a low threshold for biochemical control, is recommended. In Denmark, hyperthyroidism is more frequent than hypothyroidism. Subclinical hyperthyroidism is generally temporary. In subclinical hypothyroidism the annual progression rate to manifest hypothyroidism is 2-3%, but higher (5-10%) in the presence of thyroid autoantibodies. Treatment recommendation is related to the serum level of thyroid stimulating hormone and the presence of thyroid peroxidase autoantibodies. Hypothyroidism should be treated with lower doses of thyroxine, and the titration phase is longer. An antithyroid drug is the initial treatment in hyperthyroidism, often followed by radioiodine therapy. In Denmark, radioiodine therapy of nontoxic goitre has become more common.
在老年人中,甲状腺功能障碍通常隐匿发生,以非特异性症状和临床表现为主,这些症状和表现通常与正常衰老或年龄相关疾病有关。建议进行病例筛查,并对生化指标控制保持较低阈值。在丹麦,甲状腺功能亢进比甲状腺功能减退更常见。亚临床甲状腺功能亢进通常是暂时的。在亚临床甲状腺功能减退中,每年进展为明显甲状腺功能减退的发生率为2% - 3%,但在存在甲状腺自身抗体的情况下发生率更高(5% - 10%)。治疗建议与促甲状腺激素的血清水平以及甲状腺过氧化物酶自身抗体的存在有关。甲状腺功能减退应以较低剂量的甲状腺素进行治疗,且滴定阶段更长。抗甲状腺药物是甲状腺功能亢进的初始治疗方法,通常随后进行放射性碘治疗。在丹麦,对非毒性甲状腺肿的放射性碘治疗已变得更为普遍。